Function and Histopathology of a Cell Adhesion Molecule TSLC1 in Cancer
Authors:
- 6 January 2011
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 29 (2) , 107-112
Abstract
Even less than a decade since the discovery of TSLC1, overwhelming evidence demonstrates that the loss of TSLC1 expression by methylation-mediated epigenetic silencing or LOH is crucially implicated in various processes during tumorigenesis. Here, we summarize TSLC1 function, highlighting the concept that TSLC1 mediates the formation of tumor suppressor network via its multidomain structure and bridges extracellular adhesive activity with intracellular signaling. Next, we focus on the histopathology of TSLC1 in various cancers and the association with clinicopathological characteristics. On the basis of these, we propose that TSLC1 represents a promising biomarker for cancer diagnosis and a potential target for cancer therapy.Keywords
This publication has 41 references indexed in Scilit:
- CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the diseaseInternational Journal of Cancer, 2010
- Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cellsCancer Cell International, 2008
- Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancerBreast Cancer Research and Treatment, 2007
- TSLC1 Is a Tumor Suppressor Gene Associated with Metastasis in Nasopharyngeal CarcinomaCancer Research, 2006
- Disruption of Spermatogenic Cell Adhesion and Male Infertility in Mice Lacking TSLC1/IGSF4, an Immunoglobulin Superfamily Cell Adhesion MoleculeMolecular and Cellular Biology, 2006
- Loss of TSLC1 Causes Male Infertility Due to a Defect at the Spermatid Stage of SpermatogenesisMolecular and Cellular Biology, 2006
- Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinomaCancer, 2006
- Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4Oncogene, 2005
- The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAMBlood, 2005
- Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor DlgOncogene, 2003